| Debra M Dewig, CRNA | |
|
211 S 3rd St, Belleville, IL 62220-1915 | |
| (618) 234-2120 | |
| (618) 641-5810 |
| Full Name | Debra M Dewig |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 211 S 3rd St, Belleville, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265762835 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Jefferson | Festus, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Health Slu Hospital Anesthesia Physician Billing Llc | 3274842331 | 77 |
| Anesthesia Partners Ltd | 3870557986 | 48 |
| Acuity Anesthesiology Llc | 6305992652 | 12 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
| Entity Name | Anesthesia Partners Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043270465 PECOS PAC ID: 3870557986 Enrollment ID: O20041118000270 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
| Entity Name | Acuity Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134353030 PECOS PAC ID: 6305992652 Enrollment ID: O20090929000038 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
| Entity Name | Uap Scopes Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043636798 PECOS PAC ID: 1052535689 Enrollment ID: O20140620001426 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
| Entity Name | Ssm Health Slu Hospital Anesthesia Physician Billing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407232804 PECOS PAC ID: 3274842331 Enrollment ID: O20151013000437 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
| Entity Name | Sw Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306319769 PECOS PAC ID: 6204175649 Enrollment ID: O20190304000483 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
| Entity Name | Orthomed Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20220505000502 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
| Entity Name | Gateway Anesthesia Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457040479 PECOS PAC ID: 0840651626 Enrollment ID: O20230726000985 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Debra M Dewig, CRNA 211 S 3rd St, Belleville, IL 62220-1915 Ph: (618) 234-2120 | Debra M Dewig, CRNA 211 S 3rd St, Belleville, IL 62220-1915 Ph: (618) 234-2120 |
News Archive
A newly-launched Cancer Research UK study could be the first step towards exercise training being introduced as a new NHS treatment for prostate cancer.
Republican state officials are escalating their opposition to elements of the proposed health care overhaul.
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Reports have shown that individuals aged over 45 years are increasingly being admitted to hospitals with mental health problems related to drug use. The number of admissions due to mental health problems and behavioural problems associated with drug use, were 638 in 2007/8 and have now come to 1,182 says the report.
› Verified 1 days ago
Allan Schwartz, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 211 S 3rd St, Belleville, IL 62220 Phone: 618-234-2120 Fax: 618-641-5810 | |
Alexis Jones, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-5972 | |
Bridgette L Peek, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Anesthesia Dept, Belleville, IL 62226 Phone: 618-257-2175 | |
Jennifer R Jobe, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Drive, Belleville, IL 62223 Phone: 618-257-4076 | |
Linda Bennett, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 28 N 64th St, Belleville, IL 62223 Phone: 314-991-0985 Fax: 908-653-9305 | |
Mrs. Kristin Renee Maberry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-4076 | |
Leah D Corbitt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Drive, Anesthesia Depart Memorial Hospital, Belleville, IL 62226 Phone: 618-257-5162 |